Earnings per Share (Tables)

9 Months Ended

Oct. 28, 2017

Earnings Per Share [Abstract]

Computation of basic and diluted earnings per share

The following tables show the computation of basic and diluted loss per common share for each period presented (in thousands, except per share amounts):

	Three Months Ended						Nine Months Ended
	October 28, 2017			October 29, 2016			October 28, 2017			October 29, 2016
Basic:
Net loss	$	(17,722	)	$	(15,634	)	$	(42,967	)	$	(31,053	)
Less: Allocation of earnings to participating securities	(66		)	—			(268		)	—
Net loss allocated to common shares	(17,788		)	(15,634		)	(43,235		)	(31,053		)
Basic weighted average shares outstanding	27,602			27,155			27,468			27,066
Basic loss per share	$	(0.64	)	$	(0.58	)	$	(1.57	)	$	(1.15	)
	Three Months Ended						Nine Months Ended
	October 28, 2017			October 29, 2016			October 28, 2017			October 29, 2016
Diluted:
Net loss	$	(17,722	)	$	(15,634	)	$	(42,967	)	$	(31,053	)
Less: Allocation of earnings to participating securities	(66		)	—			(268		)	—
Net loss allocated to common shares	(17,788		)	(15,634		)	(43,235		)	(31,053		)
Basic weighted average shares outstanding	27,602			27,155			27,468			27,066
Add: Dilutive effect of stock awards	—			—			—			—
Diluted weighted average shares outstanding	27,602			27,155			27,468			27,066
Diluted loss per share	$	(0.64	)	$	(0.58	)	$	(1.57	)	$	(1.15	)

Number of anti-dilutive securities excluded from computation of diluted loss per share

The number of shares attributable to SARs and non-vested stock grants that would have been considered dilutive securities, but were excluded from the calculation of diluted loss per common share because the effect was anti-dilutive were as follows (in thousands):

	Three Months Ended		Nine Months Ended
	October 28, 2017	October 29, 2016	October 28, 2017	October 29, 2016
Number of anti-dilutive shares due to net loss for the period	—	20	—	42
Number of anti-dilutive SARs due to exercise price greater than average market price of our common stock	113	187	129	198